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The heterotrimeric NatC complex, comprising the catalytic Naa30 and the two auxiliary
subunits Naa35 and Naa38, co-translationally acetylates the N-termini of numerous eukar-
yotic target proteins. Despite its unique subunit composition, its essential role for many
aspects of cellular function and its suggested involvement in disease, structure and
mechanism of NatC have remained unknown. Here, we present the crystal structure of the
Saccharomyces cerevisiae NatC complex, which exhibits a strikingly different architecture
compared to previously described N-terminal acetyltransferase (NAT) complexes. Cofactor
and ligand-bound structures reveal how the first four amino acids of cognate substrates are
recognized at the Naa30–Naa35 interface. A sequence-specific, ligand-induced conforma-
tional change in Naa30 enables efficient acetylation. Based on detailed structure–function
studies, we suggest a catalytic mechanism and identify a ribosome-binding patch in an
elongated tip region of NatC. Our study reveals how NAT machineries have divergently
evolved to N-terminally acetylate specific subsets of target proteins.
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N-terminal acetylation (Nt-acetylation) is one of the mostabundant covalent protein modifications, affecting ~50%of the yeast and 80–90% of the human proteome1–3. The
transfer of an acetyl group from acetyl-coenzyme A to the free α-
amino group on the N-terminus of substrate proteins is catalyzed
by N-terminal acetyltransferases (NATs), and is considered to be
irreversible, as no Nt-deacetylase has been identified so far4. The
acetyl group alters the electrostatic properties of the substrate N-
terminus, which can affect protein folding, stability, half-life,
interactions, and subcellular targeting5–11. Alteration of Nt-
acetylation is implicated in several diseases, including cancers and
developmental disorders12.
All eukaryotes contain five conserved NATs, termed NatA to
NatE13, which act co-translationally on nascent polypeptide
chains, as they emerge from the ribosomal exit tunnel14–16. In
addition, higher eukaryotes express the Golgi-bound NatF17,
while plants and animals possess the kingdom-specific NatG18
and NatH19, respectively. All NATs contain a catalytic subunit,
which belongs to the GCN5-related N-acetyltransferase (GNAT)
superfamily20. In addition, NatA and NatB possess one, and NatC
two auxiliary subunits4. NatE is composed of the catalytic subunit
Naa50 and both NatA subunits: the catalytic subunit Naa10 and
the auxiliary subunit Naa15 (refs. 14,21,22).
NatA has the largest number of substrates and acetylates N-
termini bearing a small amino acid at position 1, after the initiator
methionine has been removed by methionine aminopeptidases
(MetAP)2,9,23,24. NatB acetylates N-termini starting with
methionine, followed by a residue with an acidic or amide side
chain25–27. NatC acetylates protein N-termini starting with
methionine, followed by a hydrophobic or amphipathic amino
acid9,25,28–33, with amino acids at positions 3 and 4 also con-
tributing to NatC recognition34. The substrate specificity profiles
of NatE and NatF partially overlap with that of NatC in vitro3,21
or when expressed ectopically in yeast35. Together, these three
Nt-acetylate ~21% of the human proteome4.
The evolutionarily conserved heterotrimeric NatC complex is
composed of the catalytic subunit Naa30, a large auxiliary subunit
Naa35 and a small auxiliary subunit Naa38 (refs. 13,30,31).
NatC-dependent acetylation targets various substrate proteins to
specific subcellular sites, including tRNA-specific methyl-
transferase Trm1-II to the inner nuclear membrane36, the human
ADP-ribosylation factor-like protein 8b to lysosomes31,37 and
Arf-related protein 1 (hARFRP1) and its yeast ortholog
ADP-ribosylation factor-like protein 3 (yArl3) to the trans-Golgi
network (TGN). This latter localization is mediated by an inter-
action of the acetylated N-terminus with the trans-Golgi-specific
transmembrane protein hSys1/Sys1p (refs. 32,38). Interestingly,
while depletion of hARFRP1 in HeLa cells alters the structure of
the TGN39, depletion of hNaa30 induces the fragmentation of the
entire Golgi stack40, suggesting additional NatC targets at
the Golgi.
The wide range of biological processes that include targets for
NatC-mediated Nt-acetylation, make it essential for proper cell
growth and development in eukaryotes. In yeast, deletion of any
of the three subunits results in loss of in vivo NatC activity and
diminished growth at 37 °C on media containing non-
fermentable carbon sources. It has therefore been suggested that
NatC is required for mitochondrial function30. Indeed, depletion
of human Naa30 results in reduced expression of mitochondrial
proteins, loss of mitochondrial membrane potential, and mito-
chondrial fragmentation33. NatC-dependent Nt-acetylation of the
L-A virus major capsid protein Gag is required for viral particle
assembly in Saccharomyces cerevisiae28,30. NatC is also crucial for
zebrafish development; knockouts of NAA30 or NAA35 led to
decreased cell proliferation, increased apoptosis, and poor blood
vessel formation, resulting in embryonic lethality41. In the plant
kingdom, downstream targets of NatC Nt-acetylation include
photosystem II core proteins D1 and CP47 in Arabidopsis thali-
ana, with implications for photosynthesis and plant growth42. In
addition, knockdown of NatC subunits in human cells results in
reduced cell growth and p53-dependent apoptosis31.
A strong upregulation of NAA30 has been observed in glio-
blastoma, and a NAA30-knockdown in glioblastoma-initiating
cells (GICs) reduced their viability, sphere-forming ability, and
hypoxia tolerance43. Moreover, mice transplanted with GICs in
which NAA30 was knocked down show prolonged survival
compared to control animals transplanted with unmodified GICs,
indicating that NatC may serve as a therapeutic target in cancer.
Interestingly, a nuclear localization of Naa30 was observed in
GICs and, more sporadically, in neuronal stem cell cultures43.
The nuclear localization is specific to a splice variant of human
NAA30, which encodes a truncated protein missing parts of the
GNAT-fold. The truncated version is also abundantly expressed
in thyroid cancer tissues and other human cancer cell lines44. In a
recent study, a potentially pathogenic de novo mutation in
NAA35 was identified in patients with cerebral palsy, a hetero-
geneous group of disorders affecting movement and posture45.
Recently, crystal and cryo-EM structures of several NATs have
been reported21,24,46–52, but the structure of the heterotrimeric
NatC complex has remained elusive. Here, to obtain insights into
the tertiary and quaternary assembly of NatC, we determined its
structure by X-ray crystallography and elucidated the mechanism
of substrate recognition. A structure–function approach yielded
insights into substrate specificity and catalysis, leading us to
propose a refined reaction scheme for NatC catalysis. We also
identified a ribosome-binding patch on the NatC surface and
suggest a model for the NatC–ribosome complex.
Results
Overall structure of NatC. To prepare the NatC complex for
structural studies, the three subunits of S. cerevisiae NatC were
co-expressed in Escherichia coli (Supplementary Figs. 1 and 2).
The catalytic subunit Naa30 was designed as a truncation con-
struct lacking 17 non-conserved residues at the C-terminus,
analogously to a previously crystallized NatA construct24. During
an initial purification, a partial proteolytic degradation of eleven
non-conserved residues at the C-terminus of subunit Naa38 was
identified by MALDI-MS, and, consequently, these 11 residues
were also deleted (Supplementary Fig. 3a, b). The final homo-
geneous NatC preparation used for kinetic and structural studies
(Supplementary Fig. 3c, d) therefore contained subunits
Naa30ΔC17 (residues 1–159), full-length Naa35 (residues 1–733),
and Naa38ΔC11 (residues 1–77).
Structures of the selenomethionine-derivatized (NatC, apo)
and native, CoA-bound (NatC•CoA) complex were determined
to 2.40 and 2.45 Å resolution, respectively. Both crystallized in
space group P212121. The derivatized structures were solved by
single-wavelength anomalous diffraction (SAD) and refined to
Rwork and Rfree values of 19.5% and 22.3%, respectively (Table 1).
The structure of CoA-bound NatC was solved by molecular
replacement using the ligand-free NatC structure and refined to
Rwork and Rfree values of 20.3% and 23.6%, respectively.
NatC forms a heterotrimeric complex, containing the catalytic
subunit Naa30, the small auxiliary subunit Naa38 and the large
auxiliary subunit Naa35 (Fig. 1a). Naa30 adopts the typical,
mixed α–β, GNAT-fold. The central conserved CoA-binding
motif20 harbors a CoA ligand in the NatC•CoA structure
(Supplementary Fig. 4a). With RMSDs of 1.6 and 1.7 Å, Naa30
is most similar to the archaeal NAT ortholog Ard1 (ref. 53) and
the Naa10 subunit of the Schizosaccharomyces pombe NatA
complex24, respectively (Supplementary Fig. 4b).
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Naa35 is mostly α-helical and, in addition, contains three short
β-strands in the N-terminal region and two β-strands at the C-
terminus (Supplementary Fig. 2). Helix α21, together with the C-
terminal end of α20, protrude by ~30 Å from the central body,
thereby forming an extension, which we refer to as the “Naa35
tip”. A DALI search did not yield any closely related relatives of
Naa35, indicating a unique fold.
In agreement with previous predictions54, Naa38 adopts an Sm
fold, with an N-terminal α-helix, followed by a strongly bent five-
stranded β-sheet55. An additional short α-helix is present at the
C-terminus. A DALI search revealed that Naa38 is most similar
to the spliceosomal Lsm4 (RMSD of 1.8 Å over 72 Cα atoms;
Supplementary Fig. 4c–f), which is part of the donut-shaped,
hetero-heptameric Lsm2–8 ring that binds snRNA U6 in its
center56. However, Naa38 differs from other Lsm proteins, as it
lacks the conserved IRG motif that mediates association with
small nuclear RNAs54.
Naa35 is the central assembly hub of the NatC complex. The
large auxiliary subunit Naa35 acts as the central assembly hub of
the NatC complex, forming extensive interactions with Naa30
and Naa38 (Fig. 1b). The elongated Naa35 N-terminus wraps
around almost the entire circumference of Naa38, burying a
surface area of 1970 Å2. As Naa35 extends around Naa38, it
connects it to Naa30, thereby limiting the direct contact between
the catalytic and the small auxiliary subunit to 260 Å2. The
remainder of Naa35 wraps around Naa30 in a more condensed,
ring-like structure covering three quarters of its circumference
and burying another 1890 Å2.
The quaternary assembly of the three NatC subunits results in
the formation of a tunnel in the center of the NatC complex
(Fig. 1c). This tunnel is surrounded by loop regions of Naa30 and
Naa35, which comprise the peptide-binding site (see below). The
tunnel extends to a deep groove that contains the active site of the
complex and accommodates the acetyl-CoA cofactor-binding site.
Interactions between the three NatC subunits are mediated by
several evolutionary conserved contacts (Supplementary Fig. 5).
While the interface between Naa30 and Naa35 is dominated by
hydrogen bonding interactions, the β1–α2–loop–β2 segment of
Naa35 forms extensive hydrophobic interactions with Naa38.
Table 1 Data collection and refinement statistics.
NatC, apo (SeMet)a NatC•CoA (native)a NatC•CoA•MFHLV (native)a NatC•CoA•MLRFV (native)a
Data collection
Space group P21 21 21 P21 21 21 P21 21 21 P21 21 21
Cell dimensions








α, β, γ (°) 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90









Rsym (%)c 12.8 (133.2) 14.8 (159.5) 16.6 (94.6) 19.4 (150.8)
I/σ (I)c 11.3 (1.2) 10.9 (1.1) 8.4 (1.5) 9.3 (1.2)
CC1/2 (%)c 99.8 (56.2) 99.7 (58.6) 99.1 (56.4) 99.6 (54.1)
Completeness (%)c 99.6 (97.9) 99.9 (99.4) 98.7 (98.6) 99.5 (96.0)










No. of reflectionsd 45,030 (4302) 42,170 (4132) 23,299 (2274) 28,783 (2749)
Rwork/Rfreee (%) 19.5/22.3 20.3/23.6 19.6/24.8 20.4/24.8
No of atoms
Protein 7718 7806 7753 7734
Ligand/ion 100 122 86 84
Water 181 190 52 93
B factors (Å2)
Average 65.7 64.5 63.5 67.4
Protein 66.0 64.6 63.6 67.6
Ligand/ion 72.5 79.4 67.4 78.3
Water 51.6 50.2 39.8 44.4
RMS deviations
Bond lengths (Å) 0.004 0.004 0.003 0.004
Bond angles (°) 0.90 0.92 0.86 0.85
Ramachandran plot (%)
Most favored 98.5 98.9 98.6 98.5
Allowed 1.5 1.1 1.4 1.5
Outlier 0 0 0 0
Rotamer outliers (%) 0.3 0.5 0.34 0.68
Clashscore 4.0 3.9 3.9 5.4
PDB accession code 6YGA 6YGB 6YGC 6YGD
SeMet selenomethionine.
aData are from one crystal for each structure.
bValues in parentheses are for the highest resolution shell.
cValues are calculated for separately counted Friedel’s pairs in the SeMet-substituted apo structure.
dFriedel pairs were merged during refinement.
eRfree was calculated with 5% of the reflection data.
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Moreover, the β-sheet of Naa38 is extended by three short β-
strands from the Naa35 N-terminus, forming a bifurcated,
antiparallel β-sheet. Thus, within the NatC complex, the Naa38
β-sheet is not available for homo- or hetero-oligomeric interac-
tions, unlike in the Lsm2–8 assembly (Supplementary Fig. 4e, f).
In agreement with the structural data, deletion of the first 44
residues of Naa35 disrupted the interaction with Naa38. In
contrast, deletion of the non-conserved N-terminal α1 helix
(Naa35ΔN17) was not sufficient to disrupt NatC integrity
(Fig. 1d).
Comparison of NatC with heterodimeric NatA and NatB
complexes. A comparison of the heterotrimeric NatC complex
with the heterodimeric NatA24 and NatB50 complexes revealed
remarkable differences in their tertiary and quaternary structures
(Fig. 2). All NAT complexes contain a catalytic subunit, with a
conserved GNAT architecture. While NatA and NatB have rela-
ted, single auxiliary subunits, NatC possesses two unrelated
auxiliary subunits. Strikingly, the relative position of the NatC
catalytic and auxiliary subunits is opposite to their arrangement
in NatA and NatB. Whereas the auxiliary subunits Naa15 (NatA)
and Naa25 (NatB) primarily engulf the N-terminal part of their
catalytic subunits, Naa35 (NatC) additionally encloses the C-
terminal half. In NatC, the β6–β7 loop, which is necessary for
substrate binding, is in direct contact with the auxiliary subunit
Naa35. In NatA and NatB, the β6–β7 loop makes no contact with
the corresponding auxiliary subunit. Furthermore, NatA and
NatB auxiliary subunits are necessary for the proper positioning
of the catalytic α1–loop–α2 region, and hence for full catalytic
activity24,50. In NatC, helix α2 of Naa30 is in contact with both
auxiliary subunits Naa35 and Naa38. However, in contrast to
NatA and NatB, α1 in Naa30 forms no contacts to either of the
two auxiliary subunits.
Substrate recognition in NatC. Colorimetric activity assays
were performed to kinetically characterize the activity of NatC.
Short decameric peptides were used as substrates, in which the
five initial N-terminal residues corresponded to the sequence of
cognate NatC substrates (Fig. 3a, Table 2, and Supplementary
Figs. 6 and 7). A peptide containing the N-terminus of S. cer-
evisiae Arl3 (yArl3) was Nt-acetlyated by NatC with a kcat of
4.2 ± 0.3 s−1 and a Km of 140 ± 20 µM. A comparable activity
was observed for a peptide with the N-terminal sequence of
hARFRP1, the human ortholog of yArl3, suggesting that
species-specific differences in the N-terminal sequences
between yArl3 and hARFRP1 are not due to adaption to their
respective NatC ortholog. A peptide comprising the five initial
N-terminal residues of the major capsid protein Gag, exhibited




























































































































































































Fig. 1 Overall structure of the NatC complex bound to coenzyme A. a Cartoon representation of NatC bound to CoA (stick format). b Topology plot of
NatC. Triangles represent β-strands, small triangles indicating sheets with ≤6 residues. Circles represent α-, 310- (η), or pi- (π) helices with ≤5 residues
(small circles), 6–19 residues (medium circles) or ≥20 residues (large circles). c Magnified view of the NatC active site (cartoon with surface
representation). d SDS–PAGE analysis from NatC complexes affinity-purified via the Naa35 subunit, containing full-length (FL) Naa35 (residues 1–733),
Naa35ΔN17 (residues 18–733), or Naa35ΔN44 (residues 44–733).
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constant of NatC toward the Gag peptide is at least 20-fold
higher compared to yArl3.
To obtain insights into the substrate recognition mode and the
marked difference of NatC catalytic efficiencies toward the two
peptides, crystal structures of NatC in complex with CoA, and
either yArl3 or Gag peptide were determined to a maximal
resolution of 2.99 and 2.75 Å, respectively (Table 1). The electron
density of the peptide ligands was sufficient to model the first four
and six amino acids of the yArl3 and Gag peptide, respectively
(Fig. 3b and Supplementary Fig. 8). Moreover, clear electron
density was visible for a tightly coordinated water molecule in the
active site of the NatC complex.
The yArl3 and the Gag peptide formed several side chain and
backbone interactions, mostly with Naa30, but also with Naa35.
In both structures, the methionine sulfur atom at peptide position
1 is within hydrogen bond distance to Ser28 (Fig. 3c, d). No NatC
activity was measured for a known NatA substrate (yeast threo-
nyl-tRNA synthetase, yThrRs), which lacks an N-terminal
methionine24.
The Phe2 and Leu2 side chains of the yArl3 and Gag peptide,
respectively, were positioned in a hydrophobic pocket (the “main
peptide pocket”), which is formed by conserved residues from α2
and β4 of Naa30, as well as the short 310-helix η3 from Naa35
(Fig. 3c and Supplementary Fig. 9). While F2W and F2A
substitutions led to comparable kcat and Km values as seen for the
native yArl3 peptide, the F2R, F2Y, F2L, and F2K substitutions
resulted in 3–8-fold and the F2E substitution in a 40-fold
increased Km value (Table 2 and Fig. 3a). Also, the L2E
substitution in the Gag peptide led to an at least 13-fold decrease
of Km. Substitutions at position 2 to positively charged amino
acids (F2R and F2K) in yArl3 led to strong decreases in turnover
numbers to 3–8%.
At peptide position 3, Gag-Arg3 forms a hydrogen bond with
the protein backbone and a cation–π interaction with Naa30-
Tyr144. In addition, Naa30-Glu29 interacts with the Gag peptide
backbone. In the yArl3-bound structure, in contrast, Naa30-
Glu29 forms an alternative hydrogen bond with yArl3-His3 and
does not contact the peptide backbone. Glutamate substitutions at
position 3 massively increased Km and reduced kcat for both
peptides. Interestingly, the H3A substitution in yArl3 led to kcat
and Km values that were similar to those of the Gag peptide,
suggesting that an imidazole side chain at peptide position 3
interferes with full catalytic activity.
Only in the Gag peptide, the fourth peptide residue, Phe4,
deeply inserts into a second hydrophobic surface generated by
Naa30 and Naa35, the “extended pocket” (Fig. 3c and
Supplementary Fig. 9). The yArl3-Leu4 side chain is at the
periphery of this pocket. Glutamate substitutions at position 4 led
to strong increases in Km for both peptides. For the Gag peptide,
kcat was strongly reduced in addition. Similar to the yArl3-H3A
substitution, also the yArl3-L4A variant exhibited a strong
increase in kcat and a strongly reduced Km value. Furthermore,
a peptide derived from the N-terminus of yeast actin, a known
NatB substrate50 with acidic residues at positions two and four,
was not acetylated by NatC.
Val5 in the Gag peptide occupies the same position as Leu4 of
yArl3, whereas residue 5 is not resolved for yArl3. Glutamate
substitutions at position 5 only moderately affected the specificity









































































Fig. 2 Structural comparison of the NatC complex. Comparison of CoA-bound S. cerevisiae NatC with acetyl-CoA-bound S. pombe NatA (pdb code 4KVO)
and CoA-bound Candida albicans NatB (5K04). The catalytic subunits (cyan) are in the same orientation. The boxed areas are magnified at the bottom and
show the interactions of the α1–loop–α2 segment and β6–β7 loop (cartoon representation), with the auxiliary subunits (surface representation).
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To further explore the differences between the yArl3 and Gag
peptides, yArl3/Gag hybrids with single amino acid substitutions
at positions 2–4 were introduced in the yArl3 peptide. While the
F2L hybrid exhibited a strongly reduced specificity constant
compared to yArl3, the H3R and L4F hybrids approached Km and
kcat values of the Gag peptide (Fig. 3a and Table 2). These results
highlight the importance of positions 3 and 4 for efficient
substrate acetylation.
Peptide ligand-induced conformational changes. The higher
turnover number of the Gag peptide compared to yArl3 suggests
favorable structural rearrangements of active site residues. With
an RMSD of 0.218 Å, binding of CoA induced only minor
structural changes in the catalytic subunit compared to the apo
structure. However, binding of yArl3, and, especially, the Gag
substrate, led to large conformational changes (Fig. 3d and Sup-
plementary Fig. 10a). In particular, binding of the Gag peptide
induced a marked constriction of the central tunnel in NatC
(Supplementary Fig. 10b). The α1–α2 loop of Naa30 moved ~2.8
or 3.5 Å upon binding of the yArl3 or Gag peptide, respectively.
In the peptide-free NatC structures, Leu27 in the α1–α2 loop is
positioned in a pocket in between helices α1 and α2. Binding of
Gag induces a flipping of Leu27, allowing recognition of the N-
terminal methionine, which is sandwiched between Leu27 and
Tyr145 of Naa30. In contrast, the Leu27 side chain appears to be
flexible in the yArl3 structure (Supplementary Fig. 8b).
In contrast to the yArl3 peptide, binding of the viral Gag
peptide induced a large conformational rearrangement of the β6–
β7 loop in Naa30. Naa30-Asn147 forms a hydrogen bond with
Naa35-Gln106 in the apo and CoA/yArl3-bound NatC structures,
but traversed a distance of 8.8 Å in the Gag-bound structure to
form an intramolecular hydrogen bond with Naa30-Glu120.
Moreover, Naa30-Leu146 moved ~5 Å toward Gag-Phe4, which
complements the extended peptide pocket. Thus, NatC exhibits a
sequence-specific, peptide ligand-induced conformational change
of the β6–β7 loop.
Interestingly, the Naa30 β6–β7 loop in the Gag-bound
structure adopts a conformation that strongly resembles that of

































































































































































































































































Fig. 3 NatC substrate recognition. a Specificity constants of NatC WT toward various decameric substrate peptides. The N-terminal five residues are
shown, with all peptides ending on -GSRRR. Data represent means ± SD calculated from kcat and Km values of independent experiments considering the
propagation of uncertainty. The number of repetitions is provided in Table 2. Four peptides exhibited Km values below the detection limit of the colorimetric
assay and were assumed to be <20 µM (Supplementary Fig. 6). Thus, the bar graphs for these peptides (marked with “>”) represent the lower bound of the
specificity constant and no error bar is provided. b Substrate peptides in the NatC•CoA•MFHLV (orange) and NatC•CoA•MLRFV (magenta) structures.
c Magnified views into the active sites of the two peptide-bound NatC complexes, shown in the same orientation. Hydrogen bonds are indicated as black
dashed lines. d Superposition of all four NatC structures focusing on structural changes in the α1–α2 and β6–β7 loop in Naa30.
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Naa10 conformation is similar in the presence and absence of
peptide substrate. As a result, the β6–β7 loop of NatA appears
already primed for efficient catalysis in the peptide-free state.
Catalytic mechanism of the NatC complex. A structure-based
mutagenesis approach was performed to characterize the catalytic
mechanism of NatC. All mutations of residues close to the active
site of the Naa30 subunit led to a reduction of kcat of at least 40%
(Table 2 and Fig. 4a, b). Reductions to ≤10% of wild-type (WT)
activity were observed for residues Glu29, Glu118, and Tyr130,
indicating their crucial role for catalysis. The L27A mutant
showed the most severe reduction in kcat with a minor impact on
Km, suggesting that affinity toward the substrate was not nega-
tively affected.
Mutations in the large auxiliary subunit Naa35, K59A
(Supplementary Fig. 10a), and F47A (Fig. 3c) had only moderate
effects on catalytic parameters (Table 2). A NatC construct
expressed and purified without its small auxiliary subunit Naa38
(ΔNaa38) showed a strong decrease in kcat to 6% of WT activity,
while the Km remained almost identical to WT, indicating that
the small subunit Naa38 is crucial for NatC activity. On the basis
of this mutagenesis study and previous functional data of other
NAT complexes, we propose a catalytic mechanism for the NatC
complex (Fig. 4c), which is detailed in the discussion.
Table 2 Catalytic parameters for wild type and mutant NatC with various substrates.
Enzyme Substrate N-terminusa Substrate description kcat (s−1) kcat/WTb,d Kmc (µM) Km/WTb,d n
NatC WTb MFHLV- yArl3 4.2 ± 0.3 1.0 140 ± 20 1.0 5
MYTLL- hARFRP1 3.2 ± 0.3 0.77 190 ± 40 1.3 4
MWHLV- yArl3-F2W 3.4 ± 0.4 0.80 140 ± 60 1.0 4
MYHLV- yArl3-F2Y 2.5 ± 0.1 0.60 520 ± 60 3.6 4
MKHLV- yArl3-F2K 0.35 ± 0.01 0.083 1190 ± 60 8.3 3
MRHLV- yArl3-F2R 0.135 ± 0.003 0.032 450 ± 80 3.1 3
MAHLV- yArl3-F2A 5.1 ± 0.3 1.2 80 ± 10 0.55 3
MFALV- yArl3-H3A 6.9 ± 0.5 1.6 <20* <0.14 3
MFHAV- yArl3-L4A 8 ± 1 1.8 <20* <0.14 4
MEHLV- yArl3-F2E 4 ± 1 0.95 6000 ± 2000 40 5
MFELV- yArl3-H3E 0.18 ± 0.01 0.043 3600 ± 200 25 3
MFHEV- yArl3-L4E 3.2 ± 0.1 0.76 2100 ± 300 15 3
MFHLE- yArl3-V5E 6.7 ± 0.3 1.6 620 ± 90 4.3 3
MLHLV- yArl3/Gag-F2L 5.6 ± 0.2 1.3 730 ± 50 5.1 3
MFRLV- yArl3/Gag-H3R 9 ± 2 2.1 27 ± 2 0.19 4
MFHFV- yArl3/Gag-L4F 10 ± 2 2.5 28 ± 4 0.19 4
MLRFV- Gag 12 ± 1 1.0 <20* 1.0 3
MERFV- Gag-L2E 10.3 ± 0.8 0.86 270 ± 30 13 3
MLEFV- Gag-R3E 0.72 ± 0.08 0.060 3800 ± 300 190 3
MLREV- Gag-F4E 1.01 ± 0.07 0.084 1700 ± 100 86 3




L27A MFHLV- yArl3 0.010 ± 0.005 0.0023 80 ± 30 0.56 4
S28A 1.8 ± 0.1 0.43 270 ± 30 1.9 3
E29A 0.24 ± 0.01 0.058 160 ± 30 1.1 4
E29Q 0.18 ± 0.02 0.043 250 ± 40 1.7 3
Y31F 0.45 ± 0.01 0.11 230 ± 50 1.6 3
Y80A 2.5 ± 0.3 0.59 550 ± 70 3.9 3
Y80F 1.68 ± 0.01 0.40 430 ± 60 3.0 3
E118A 0.40 ± 0.03 0.10 320 ± 30 2.3 3
E118Q 0.60 ± 0.02 0.14 430 ± 60 3.0 4
E120A 0.88 ± 0.04 0.21 260 ± 10 1.8 3
E120Q 1.01 ± 0.05 0.24 300 ± 60 2.1 4
Y130A 0.057 ± 0.002 0.013 200 ± 60 1.4 4
Y130F 0.08 ± 0.01 0.020 120 ± 20 0.80 4
Y145F 1.02 ± 0.09 0.24 230 ± 10 1.6 3
NatC-Naa35 mutations
F47A MFHLV- yArl3 2.3 ± 0.1 0.55 160 ± 10 1.1 3
K59A 2.2 ± 0.3 0.53 191 ± 8 1.3 3
Tip1e 4.2 ± 0.4 1.0 180 ± 10 1.2 3
NatC-Naa38 deletionf MFHLV- yArl3 0.27 ± 0.04 0.063 110 ± 10 0.75 3
WT wild type.
aN-terminal five residues of the decameric substrate peptides ending on -GSRRR. Peptides with N-terminal sequences of cognate yeast NatC substrates (yArl3 and Gag) are printed in bold letters. Single
amino acid substitutions in related yArl3- and Gag-peptide variants are underlined.
bWT NatC construct (Naa30ΔC17, full-length Naa35 and Naa38ΔC11).
cKm values are for the substrates in the substrate column. The acetyl-CoA Km was calculated for NatC WT using the yArl3 substrate (Km= 30 ± 6 µM for n= 4 independent experiments). Four Km values
(*) were below the detection limit of the colorimetric assay and were assumed to be <20 µM (see Supplementary Fig. 6).
dAll normalizations are relative to NatC WT with the yArl3 peptide, except for the Gag-L2E, -R3E, -F4E, and -V5E peptides, which were compared against Gag.
eThe Naa35-Tip1 mutant contains point mutations: K500A, K501A, K503A, and K504A.
fThe Naa38 deletion construct consist of Naa30ΔC17 and full-length Naa35 only. Where kcat is ND (not determined), activity could not be detected. Values for kcat and Km represent means ± SD of n
independent experiments (see last table column).
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NatC–ribosome interaction. All major NATs, i.e., NatA to NatE,
are associated with mono- and polyribosomes14–16. Using co-
sedimentation assays, two conserved electropositive regions
(EPR) in NatA were shown to mediate its ribosome interaction57.
We also identified several distinct EPRs in NatC (Fig. 5a). The
four most prominent ones, EPR1–EPR4, were selected for
mutational studies. EPR2, located on the Naa35 tip, contains 11
positively charged residues, which were divided into two sets
(Tip1 and Tip2). For each NatC mutant, between three and four
positively charged residues were substituted with alanine. Our co-
sedimentation assay showed that the electropositive Naa35 tip
region is necessary for association of NatC with the ribosome,
whereas ribosome binding was not affected for the other EPR
mutants (Fig. 5b, c and Supplementary Fig. 11). The Tip1 mutant
showed no significant difference in kcat and Km compared to
NatC, arguing against major structural disturbances in NatC
induced by the mutations. Interestingly, Naa38 does not seem to
be required for the NatC–ribosome association, as the
Naa35–Naa30 heterodimer associated with ribosomes similarly to
NatC.
S. cerevisiae NAA35-deletion strains (naa35Δ) were reported to
exhibit reduced growth on non-fermentable carbon
sources30,58,59, and we confirmed these results (Fig. 5d and
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Fig. 4 Proposed catalytic mechanism for the NatC complex. a The active site of the NatC complex in NatC•CoA•MFHLV. The proposed catalytic water is
indicated by a red sphere. The position of acetyl-CoA (green) was modeled based on a superposition of the Ard1•Acetyl-CoA structure (4LX9) with
Naa30. b Turnover numbers (kcat) of NatC WT and NatC mutants with the yArl3 substrate peptide. Data represent mean ± SD of independent experiments.
The number of repetitions is provided in Table 2. c Proposed catalytic mechanism for the NatC complex (see discussion). d Sequence logos of regions near
the active site, generated from multiple sequence alignments of 18 different species (see “Methods”). Black circles indicate proposed catalytic residues and
+ signs, substrate-binding residues. e Superposition of NatC•CoA•MLRFV, Naa50•CoA-Ac-MGLP (3TFY) and Naa60•CoA-Ac-MKAV (5ICV). For
simplicity, only NatC ligands are shown. The proposed catalytic water (sphere) is indicated in all NATs.
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NAA35-WT, and the Tip1 or Tip2 variants rescued the growth
phenotype of the naa35Δ strain on glycerol. Thus, the EPR2
region in the Naa35 tip region appears not essential for yeast
growth on glycerol.
Discussion
In this work, we report the crystal structure of the conserved
heterotrimeric NatC complex. We show that the large auxiliary
subunit Naa35 is the central scaffold of NatC, which forms
extensive interactions with Naa30 and Naa38. The architecture
of the complex is strikingly different from that of other NAT
complexes, which is mainly due to the unique architecture and
interaction network of the Naa35 subunit. By characterizing the
peptide-binding site located in between the catalytic Naa30
and the Naa35 subunits, our works explains the substrate spe-
cificity of NatC. Furthermore, we reveal how substrate binding
leads to correct positioning of the catalytic machinery, and
finally identify residues important for catalysis and ribosome
interaction.
Naa35 mediates the unique assembly of NatC into a highly
intertwined complex. Its N-terminus mediates the interaction
with Naa38, while the C-terminal residues engage in an intricate
interaction network with the catalytic subunit. Besides this scaf-
folding function, Naa35 also mediates the interaction with the
ribosome via an elongated tip region. We did not find close
relatives of Naa35 in the PDB database, suggesting that Naa35 has
evolved a specialized function in the NatC complex. Deletion of
any of the three NatC subunits in yeast leads to a complete loss of
Nt-acetylation of a NatC model peptide30. On the other hand, Nt-
acetylation of yArl3 is abolished in a naa30Δ strain, but still
present in naa38Δ yeast cells38. Accordingly, we show that a
Naa38-deletion construct of NatC still displayed residual activity
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Fig. 5 NatC–ribosome interaction. a Electrostatic surface potential projected on the surface of the NatC•CoA structure. Residues within electropositive
regions (EPRs) that were substituted with alanine in NatC mutants constructs are specified in brackets. b Representative western blot of a NatC/ribosome
co-sedimentation assay. NatC constructs in the supernatant (S) and pellet (P) fractions were immunodetected via a FLAG-tag at the Naa35 N-terminus,
yeast ribosomes via the ribosomal protein uL30. Co-sedimentations assays were performed in triplicate (all replicates are shown in Supplementary Fig. 11).
c Quantification (chemoluminescence band intensities) of the NatC fraction in the pellet (P/(S+ P)). Data represent mean ± SD (n= 3 independent
experiments). NatC mutants were compared against NatC WT using a one-way ANOVA analysis with Dunnetts correction. d Serial tenfold dilutions of S.
cerevisiaeWT (BY4741) and naa35Δ (Y00294) strains, transformed with a pRS416 yeast centromere vector, carrying no insert (vector), NAA35-WT or the
NAA35-Tip1 or NAA35-Tip2 mutant genes. Cells were grown at 37 °C for 5 days on SD-ura agar plates, supplemented with 3% glycerol or 2% dextrose,
respectively.
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for a yArl3 peptide. The influence of Naa38 on catalytic activity is
likely indirect, as Naa38 is far away from the catalytic subunit and
the two subunits share only a small interaction interface. Instead,
Naa38 seems to stabilize the Naa35 N-terminus, which runs in
between Naa30 and Naa38, and forms the distal end of the
extended peptide-binding pocket. When expressed on its own,
yeast Naa30 aggregated in our hands, highlighting its dependence
on Naa35. However, the Arabidopsis homolog of Naa30 can
functionally replace all three NatC subunits in yeast, and
AtNaa35 knockout plants show no obvious phenotype42. Thus, in
contrast to the yeast counterpart, plant Naa30 can either act alone
or as part of a different multiprotein complex.
NatC acetylates substrates with an initial N-terminal methio-
nine followed by a hydrophobic/amphipathic amino acid9,25,29–34.
This substrate preference can well be explained by our two
substrate-bound NatC structures. In the peptide-free NatC
structures, Leu27 is positioned in a hydrophobic pocket in
between helices α1 and α2. In the Gag-bound structure, we
observed a repositioning of Leu27 from a hydrophobic pocket
within Naa30 toward the N-terminal methionine of the substrate
peptide, whereas Leu27 appeared flexible in the yArl3-bound
structure. We envision that the repositioning of Leu27 upon
substrate-binding primes the catalytic machinery, as the L27A
mutant exhibited the strongest catalytic reduction in our assay.
The substrate’s second amino acid is placed in the hydrophobic
main peptide pocket and shows a preference for phenylalanine,
tryptophane, or alanine. The latter is unlikely to exist in vivo, as
MetAP usually cleaves the amino-terminal methionine when it
precedes a small amino acid60, unless subsequent inhibitory
residues (e.g., Pro at position 3) restrain MetAP activity61. Ter-
ecero et al. have already qualitatively shown in yeast that also
substrate positions 3 and 4 are important for acetylation by NatC,
as glutamate substitutions at these positions prevented Nt-
acetylation34. Our peptide-bound structures reveal that Gag-Arg3
interacts with Tyr144 of the β6–β7. Furthermore, a contact of
Naa30-Glu29 with the Gag peptide backbone stabilizes active site
loops α1–α2 and β6–β7 (Fig. 3c). For the yArl3 peptide, this
interaction is sterically prevented by a hydrogen bond of yArl3-
His3 with Naa30-Glu29, which may partially account for the
reduced specificity constant of yArl3 compared to Gag. When the
steric restraints are released by the H3A substitution and, possi-
bly, the L4A substitution in yArl3, efficient catalysis is restored.
Furthermore, the Gag peptides explores an extended peptide
pocket, which can accommodate another large hydrophobic
amino acid at peptide position four. Correspondingly, the yArl3-
L4F substitution leads to reduction in Km. Our data thus suggest
that amino acids 3 and 4 of the Gag peptide induce sequence-
specific structural rearrangements in the active site that are
favorable for catalysis. This can explain the high specificity con-
stant of the Gag peptide, which likely reflects an evolutionary
adaption of the L-A virus to ensure that all Gag protomers are Nt-
acetylated to allow an error-free, seamless assembly of the viral
capsid. Interestingly, three mitochondrial proteins acetylated by
NatC in yeast share the same four N-terminal amino acids as
Gag34, and may therefore be modified in a similarly efficient
manner.
Even though NatC, NatE, and NatF share substantially
overlapping substrate specificity in vitro9, they may have a
smaller overlap in vivo. In yeast, the Naa50 subunit of the NatE
complex lacks the optimal acetyl-CoA-binding motif and is
enzymatically inactive21,22, and NatF is completely absent13,17.
In humans, NatF is tethered to the Golgi membranes, where it
specifically acetylates transmembrane proteins17 and is thus
likely to exhibit only a minor substrate overlap with NatC.
Human Naa50 is catalytically active in its uncomplexed62 and
NatA-complexed form21. A comparison of the NatC substrate
pocket with those of human Naa50 and Naa60 reveals con-
siderable differences in the shape, hydrophobicity, and elec-
trostatic surface potential of the respective peptide-binding
pockets (Supplementary Fig. 9). The NatC pocket, which is
formed at the interface of subunits Naa30 and Naa35, is much
deeper and more confined than the peptide-binding sites in
NatE and NatF. While the NatC peptide-binding pocket is lined
by several conserved hydrophobic residues, it still exhibits a
moderate negative electrostatic surface potential as opposed to
the positive charge in NatE. This may contribute to subtle
differences in their substrate specificity. The unique substrate-
binding pocket of NatC, including a substrate-binding interface
in between the catalytic and auxiliary subunits,
offers opportunities to design small molecules that specifically
interfere with NatC function. Such compounds could be used
to explore the cellular function of NatC in more detail. In
light of the observation that NatC is upregulated in cancer
cells43, a therapeutic application of NatC inhibitors may also be
envisioned.
Based on our mutagenesis data and previously proposed
reaction schemes for GNATs24,50,63 and NAT complexes, we
present a refined catalytic mechanism for NatC (Fig. 4c). It was
proposed for human Naa50 that a tyrosine and histidine coop-
erate in the deprotonation of the amino group via a coordinated
water molecule46, and a similar situation is found in Naa60
(refs. 47,49). A glutamate was also suggested to function as the
general base in the GNAT histone acetyltransferase Gcn5 from S.
cerevisiae64 and the Salmonella typhimurium GNAT RimI, which
also employs a catalytic water65. An active site alignment of NAT
orthologs reveals that the NatC catalytic subunit Naa30 has two
potential general bases: Tyr80 and Glu118 (Fig. 4d, e). The pro-
posed catalytic water is positioned 3.5 Å away from the peptide’s
amino group and is coordinated by the hydroxyl group of the
Tyr80 side chain, the backbone carbonyl oxygen of Ile81 and the
carboxyl group of the Glu118 side chain. E118A or E118Q sub-
stitutions resulted in a ~90% reduction, and Y80A or Y80F
substitutions led to a ~50% reduction of the kcat compared to
Naa30 WT (Table 2). This suggests that Glu118 serves as the key
general base, while Tyr80 may support its function by coordi-
nating the catalytic water. The deprotonated peptide amino group
then performs a nucleophilic attack on the carbonyl carbon of the
enzyme-bound acetyl-CoA, resulting in a transient zwitterionic
tetrahedral intermediate. Simultaneously, the resultant negative
charge on the carbonyl oxygen (oxyanion) may be stabilized by
the backbone amide of Leu84. Tyr130 likely serves as a general
acid that donates a proton to break the thioester bond of the
tetrahedral intermediate. Y130A and Y130F mutants exhibited a
strongly reduced kcat, corresponding to ~1–2% of NatC WT
turnover numbers, while showing no significant changes in Km,
emphasizing the crucial role of Tyr130 in catalysis. Tyr130 is
universally conserved among NAT orthologs (Fig. 4d), and its
role as a catalytic acid was initially proposed for S. typhimurium
RimI65. Mutations in a corresponding tyrosine in NatB lead to
similar reductions in kcat (ref. 50).
After the nucleophilic attack, the nitrogen atom of the former
peptide carries a positive charge and an excess hydrogen has to be
removed in a second deprotonation step. Point mutations in the
highly conserved Glu29 exhibited reductions of kcat to 4–6% of
NatC WT turnover numbers, but the amino group of the sub-
strate peptide and the carboxyl group of Glu29 are ~9 Å apart.
Glu29 may play an indirect role in NatC catalysis, through direct
contact with cognate NatC substrate peptides, resulting in a sta-
bilization of active site loop α1–α2 and β6–β7. In NatA, muta-
tions of the corresponding glutamate showed similarly strong
reductions in kcat with negligible effects on Km (ref. 24). However,
a mutation of the corresponding glutamate in NatB increased its
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enzymatic activity by ~60% (ref. 50), pointing to alternative
functions in different NATs.
A recent cryo-EM structure of the S. cerevisiae NatA/Naa50-
ribosome complex revealed interactions with the ribosomal RNA
near the peptide exit tunnel66 (Supplementary Fig. 13a). To
explore possible binding modes of NatC with the ribosome, the
catalytic subunit of NatC was aligned with Naa10 in the NatA
complex. In the resulting model, the auxiliary subunit Naa35 is in
close contact with the surface of the ribosome. Moreover, the
peptide-binding site is in close proximity to the ribosomal exit
tunnel, and the Naa35 tip region contacts the ribosomal RNA, in
agreement with its essential role in NatC–ribosome binding
(Supplementary Fig. 13b, c). Mutations in the Naa35 tip region
did not affect yeast growth on glycerol. However, the molecular
basis for reduced growth of NatC deletion strains under non-
fermentative conditions is not clear. It may be envisaged that
the introduced mutations in the Naa35 tip only partially disturb
the NatC–ribosome interaction in vivo. Alternatively, the
NatC–ribosome interaction may not be required for the acetyla-
tion of all NatC substrates, including those implicated in yeast
growth. Clearly, more work is required to fully understand the
exact role of the co-translational activity of NatC in yeast
and human.
Taken together, the structural and biochemical studies pre-
sented in this work provide insight into the unique architecture,
substrate preference, catalysis, and ribosome interaction of NatC.
They also show how sophisticated NAT machineries have
divergently evolved to provide the cell with a broad repertoire of
N-terminally acetylated proteins.
Methods
NatC expression and purification. Genes encoding S. cerevisiae NatC subunits
Naa30 (Uniprot ID: Q03503), Naa35 (Q02197), and Naa38 (P23059) were obtained
from the Dharmacon yeast ORF collection and cloned into the pRSFDuet-1
(Novagen) expression vector (Supplementary Table 1). A NatC complex construct
(designated NatC WT), expressing the truncated NatC subunits Naa30ΔC17
(residues 1–159), full-length Naa35 (residues 1–733), and Naa38ΔC11 (residues
1–77) was used for all kinetic and structural studies. The genes encoding
Naa38ΔC11 and Naa30ΔC17 were cloned into the second multiple cloning site of
the pRSFDuet-1 vector. An additional ribosome-binding site (AAGGAGATA-
TACC) was added in front of the Naa30ΔC17 start codon. DNA encoding full-
length Naa35, preceded by a human rhinovirus 3C (HRV 3C) cleavage site, was
cloned in frame with the sequence for the His6-tag in the first MCS. For
NatC–ribosome co-sedimentation assays, an additional FLAG-tag (DYKDDDDK)
was inserted in between the HRV 3C cleavage site and Naa35. NatC point mutant
constructs were created by site-directed mutagenesis.
NatC expression vectors were transformed into E. coli BL21(DE3) cells, which
were cultured in TB medium at 37 °C to an OD600 of 0.6, followed by induction
with 100 µM isopropyl β-D-1-thiogalactopyranoside and a temperature shift to
18 °C for overnight expression. Selenomethionine-substituted NatC complex was
expressed in M9 minimal medium, supplemented with L-amino acids lysine,
phenylalanine, threonine (100 mg l−1), isoleucine, leucine, valine, and
selenomethionine (50 mg l−1)67.
Cells were isolated by centrifugation and disrupted by a microfluidizer
(Microfluidics) in lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, and 10 mM
imidazole), supplemented with 1 µM DNAse (Roche), 1 mMMgCl2, and 500 µM 4-
(2-aminoethyl)-benzolsulfonylfluorid hydrochloride (BioChemica). Cleared lysates
(~95,000 × g, 45 min, 4 °C) were incubated with 5 UmL−1 Benzonase (Merck) for
30 min at 4 °C before application to a Ni2+-sepharose column (GE healthcare).
Following a wash step (20 mM HEPES, pH 7.5, 300 mM NaCl, and 25 mM
imidazole), the NatC complex was eluted with 20 mM HEPES, pH 7.5, 150 mM
NaCl, and 60 mM imidazole. Imidazole was removed with 50 kDa molecular
weight cutoff concentrators (Amicon) and washing with size-exclusion buffer
(20 mM HEPES, pH 7.5, and 150 mM NaCl). The solution was supplemented with
1:100 (w/w) GST-tagged HRV 3C protease, 5 UmL−1 Benzonase and 1 mM
MgCl2, and incubated overnight at 4 °C. The mixture was loaded on a second Ni2+
column and washed with size-exclusion buffer. The cleaved NatC complex was
eluted with size-exclusion buffer containing 10 mM imidazole. Peak fractions were
concentrated and loaded onto a Superdex200 column (GE) equilibrated with size-
exclusion buffer. Fractions containing NatC were concentrated and flash-frozen in
liquid nitrogen. A Naa38-deletion construct of NatC (ΔNaa38), FLAG-tagged
NatC, and mutant NatC complexes were purified using the same protocol. The
selenomethionine-substituted NatC complex was purified like the native NatC
complex, except that 2.5 mM 2-mercaptoethanol was added to all buffers.
Mass spectrometry. Purified NatC complex was diluted in 0.1% trifluoroacetic
acid (TFA) to a final concentration of 10 µM and mixed with an equal volume of
saturated α-cyano-4-hydroxycinnamic acid solution in 50% acetonitrile/0.05%
TFA. A total of 0.5 µL of the sample/matrix mixture was spotted on a MALDI
target plate and measured with a mircoflex™ LRF MALDI-TOF mass spectrometer
(Bruker) using linear, positive ion mode.
NatC crystallization and structure determination. NatC was diluted to
5–6 mgmL−1 in size-exclusion buffer containing 2.5 mM 2-mercaptoethanol. The
selenomethionine-substituted NatC complex was crystallized in its apo form. CoA
was added at a 1:3 molar ratio to all native NatC proteins. In addition to CoA, the
substrate peptides MFHLVGSRRR or MLRFVGSRRR were added to two further
crystallization setups at a molar ratio of 1:5 or 1:3, respectively. Crystallization
plates were set up as sitting drops in a 96-well format with a Crystal Gryphon
dispensing robot (Art Robbins Instruments) by mixing 0.2 µL protein solution with
0.2 µL reservoir solution above an 80-µL reservoir. Reservoir solution contained
14.5–16.5% PEG 4000, 150 mM ammonium iodide, and 100 mM sodium citrate,
pH 6.1–6.3. Diffraction quality crystals appeared after 12–48 h and required
another 5 days to reach maximum dimensions. Crystals were soaked for ~10 s in
well solution containing 20% (v/v) ethylene glycol and quickly frozen in liquid
nitrogen. All datasets were collected at beamline BL14.1 at BESSY II in Berlin at a
temperature of 100 K.
The dataset of the selenomethionine-substituted NatC complex (NatC, apo) was
taken from a single crystal at a wavelength of 0.9797 Å (3600 images, 0.1° per
frame) and processed to 2.40-Å resolution using the XDS suite68. Experimental
phasing was achieved by SAD phasing with SHELXC/D/E69, using HKL2Map70
from the CCP4 interface71. An automated model building and refinement was
performed with Buccaneer72, and the model was completed manually in Coot73
and refined in Phenix74. Translation–libration–screw-rotation (TLS) refinement
employed two TLS groups for subunit Naa30ΔC17, two groups for Naa38ΔC11
and five groups for subunit Naa35.
Datasets of native, ligand-bound NatC complexes were taken from a single crystal
each, at a wavelength of 0.9184 Å and consisted of 1100 images (NatC•CoA•MFHLV)
or 1800 images (NatC•CoA and NatC•CoA•MLRFV) with an oscillation of 0.1° per
frame. All native datasets were processed with XDS to 2.45-Å (NatC•CoA), 2.99-Å
(NatC•CoA•MFHLV), or 2.75-Å (NatC•CoA•MFHLV) resolution, respectively.
Datasets were phased by molecular replacement with Phaser75 using the refined
structure of the SeMet-labeled NatC complex, followed by several rounds of manual
model building (Coot) and refinement (Phenix). All ligand occupancies were refined.
TLS was used in later stages of the refinement using the same TLS groups as for the
selenomethionine dataset plus one additional group for CoA and another for the
peptide ligand. Simulated annealing OMIT maps for CoA, substrate peptides and a
water molecule in the active site were generated with phenix.maps after performing a
simulated annealing refinement run in Phenix. Figures were prepared with the
PyMOL Molecular Graphics System, Version 2.3.1 (Schrödinger, LLC). Secondary
structure assignment for all NatC structures was done manually. NatC dimension
were calculated with the PyMOL script “Draw Protein Dimensions” (https://
pymolwiki.org/index.php/Draw_Protein_Dimensions). Interfaces and buried surface
areas between NatC subunits were calculated using the PDBe PISA webserver76. NatC
subunit structures were compared against the PDB database, using the DALI
webserver77. Structural superpositions and RMSD calculations were performed with
PyMOL. The electrostatic surface potential and surface hydrophobicity were
calculated with the PyMOL plugins APBS78 or VASCo79. Multiple sequence
alignments for Naa30, Naa35, and Naa38 were generated with Geneious (https://
www.geneious.com/) and visualized using ESPript3.0 (http://espript.ibcp.fr/).
Sequence logos of the catalytic subunits of five different NAT paralogs (Naa10, Naa20,
Naa30, Naa50, and Naa60) were generated from individual multiple sequence
alignments using the corresponding NAT orthologs from 18 different species: S.
cerevisiae, Kluyveromyces lactis, Candida albicans, Fusarium graminearum,
Physcomitrelle patens, Oryza sativa, Zea mays, A. thaliana, Populus trichocarpa,
Ricinius communis, Drosophila melanogaster, Aedes aegypti, Tribolium castaneum,
Strongylocentrotus purpuratus, Danio rerio, Xenopus tropicalis, Homo sapiens, and
Mus musculus.
Acetyltransferase assays. The acetyltransferase activity was determined using
the Ellman method, adapted from Thompson, et al.80. Reactions were carried out at
25 °C in acetylation buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 0.2 mM EDTA,
and 0.003% (v/v) Tween-20). Tween-20 was added to the buffer to reduce protein
surface adsorption. Catalytic parameters for NatC WT and mutants were deter-
mined using the yArl3 peptide (MFHLVGSRRR), containing the five N-terminal
residues of the S. cerevisiae ADP-ribosylation factor-like protein 3 (Uniprot ID
Q02804), followed by a GS linker and a triple arginine to facilitate peptide solu-
bility. Reactions were carried out as duplicates at six different peptide concentra-
tions and an acetyl-CoA concentration of 500 µM (≥10 × Km). Individual reactions
(110 µL total volume) were performed with final NatC concentrations between
50–2500 nM for 150 s for NatC WT and up to 100 min for catalytically impaired
NatC mutant complexes. At regular time intervals, 20-µL aliquots were taken from
the reaction and quenched in 40 µL quenching buffer (3.2 M guanidinium-HCl,
5 mM EDTA, 100 mM sodium phosphate, pH 6.8), containing freshly added 5,5-
dithiobis(2-nitrobenzoic acid) (DTNB) at a final concentration of 0.5 mM. A total
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of 50 µL of the quenched reactions were transferred into 384-well plates and
absorbances were measured at 412 nm with a M1000 Pro Microplate reader
(Tecan). TNB2− anion product concentration, was determined using the
Beer–Lambert law (A= ε × c × l), assuming ε= 14,150M−1 cm−1 (ref. 81). Reac-
tion background absorbances (containing quenched enzyme) were determined for
each reaction and subtracted from the absorbances of the individual reactions.
Plate background absorbances were subtracted from all reactions to account for
plate-specific imperfections. Turnover of limiting substrate did not exceed 20%.
Initial velocities were fitted by nonlinear least fit squares to the Michaelis–Menten
equation (v0 ¼ vmax S½ = Km þ ½Sð Þ) using GraphPad Prism version 6.01 to deter-
mine kcat and Km parameters. Each complete acetylation assay was performed at
least in triplicate, and the average kcat and Km and SD were calculated with
Microsoft Excel 365. The Km of acetyl-CoA for NatC WT was determined with a
fixed Arl3 peptide concentration of 1340 µM and 30–500 µM acetyl-CoA. A NatA
substrate peptide (SASEAGSRRR) containing the N-terminal five residues (after
removal of the initiator methionine) of the S. cerevisiae ThrRS (Uniprot ID:
P04801); and a NatB substrate peptide (MDSEVGSRRR) from S. cerevisiae actin
(Uniprot ID: P60010) showed no activity, even after incubating for 2 h and using a
large excess (2 µM) of NatC WT. The Gag peptide (MLRFVGSRRR), containing
the N-terminal five residues of the major capsid protein (Gag) of the S. cerevisiae
virus L-A (Uniprot ID: P32503) showed a higher specificity constant, and thus the
acetyltransferase assay was adapted: final NatC concentrations: 10–80 nM; total
reaction times: as short as 60 s; peptide concentrations: 30–500 µM; total reaction
volume: 226 µL, with larger aliquots of 72 µL taken. Aliquots were quenched in
36 µL of 2× quenching buffer (6.4 M guanidinium-HCl, 10 mM EDTA, 200 mM
sodium phosphate, pH 6.8). Two times 50 µL of each quenched reaction were
transferred into separate microplate wells to obtain duplicate absorbance readings,
which were averaged. Further peptides, exhibiting a Km > 50 µM, were measured as
described for the yArl3 peptide. Peptides exhibiting a Km < 50 µM were measured
as described for the Gag peptide.
All peptides were synthesized by ProteoGenix (Schiltigheim, France) with a purity
of ≥95% and with TFA exchanged for HCl. Peptides were solubilized in acetylation
buffer and peptide concentrations were determined photometrically from TNB2−
product concentration, formed in an end point acetylation reaction. For each peptide
stock, five different dilutions were incubated together with an excess of CoA and 2 µM
NatC WT in acetylation buffer. Reaction aliquots were quenched after 1.5 and 2 h
with a twofold excess of quenching buffer, containing 0.5mM DTNB. Measurements
taken after 2 h did not show a significant increase of absorbance compared to the 1.5 h
time point and both readings were within 5% of one another.
Purification of yeast 80 S ribosomes. Yeast 80 S ribosomes were purified
according to a protocol adapted from Magin, et al.57. S. cerevisiae strain YA2488
was plated out on YPD-agar plates (1% yeast extract, 2% peptone, and 2% glucose),
and used to inoculate a 20 mL preculture of YPD, which was incubated at 30 °C
for 7 h. A volume of 8 L of YPD was inoculated to an OD600 of 0.001 and grown at
30 °C to an OD600 of 2 (stationary phase). Cells were pelleted at 8000 × g, 5 min,
4 °C (Beckman Rotor JLA9.1000), resuspended in YP medium (1% yeast extract,
2% peptone, and no glucose), and incubated for 10 min, 250 r.p.m., 30 °C, to ensure
that all ribosomes would be in the “apo” form, without nascent chain or tRNA. The
following cell lysis steps were all carried out at 4 °C: cells were pelleted by cen-
trifugation at 8000 × g, 5 min (Beckman Rotor JLA9.1000) and resuspended in
buffer A (30 mM HEPES, pH 7.5, 50 mM KCl, 10 mM MgCl2, 8.5% sorbitol, 2 mM
DTT, and 0.5 mM EDTA). Cells were centrifuged again at 8000 × g, 5 min, the
pellet was weighed, and resuspended in lysis buffer (buffer A+ one cOmplete mini
EDTA-free protease inhibitor tablet (Roche 11836170001), 1 unit µL−1 RNAsin
(N261B, Promega), and 800 µgmL−1 heparin) to a final concentration of 200% (w/v).
Glass beads (G8772 sigma) were added to the resuspension and lysis was performed
by vortexing for 30 s, followed by 30 s on ice, repeated four times. To obtain the yeast
lysates, the resuspension was centrifuged at 9000 × g, 10min (rotor Beckman TA-
10.250), and the supernatant was collected. The absorbances at 260 and 280 nm were
measured. To isolate the 80 S monosomal ribosome fraction, yeast lysate (A260= 200)
was underlaid with 1mL 30% sucrose in 80 S buffer (20mM HEPES, pH 7.6, 100mM
potassium acetate, 5 mM MgCl2, and 2mM DTT) and centrifuged 70,000 × g, 18 h
(Beckman ultracentrifuge, rotor mla80). The pellet was collected, and added at a
concentration of A260= 100, to the top of a 15–30% sucrose gradient, which was
prepared by underlying 15% sucrose in 80 S buffer with 30% sucrose in 80 S buffer,
and mixing (Gradient Master, BIOCOMP, short settings). The gradients were then
spun at 92,703 × g, 6 h, using a SW32 Ti Beckman swing-out rotor, and then loaded to
a polysome collector (LKB). Fractions containing 80 S monosomes were pooled and
centrifuged at 127,959 × g, 14 h (Beckman MLA-80 rotor). The pellet containing the
80 S yeast ribosomes were resuspended in 20mM HEPES pH 7.6, 50mM potassium
acetate, 5 mM MgCl2, and 2mM DTT to give a final concentration of 2 µM.
NatC–ribosome sedimentation assay. The sedimentation assay was adapted from
the protocol described by Magin et. al.57. NatC and ribosomes were combined to
final concentrations of 1 µM and 0.8 µM, respectively in 80 S buffer (20 mM
HEPES, pH 7.5, 50 mM KOAc, 5 mM Mg(OAc)2, 2 mM DTT, and 0.003% (v/v)
Tween-20). Tween-20 was added to reduce unspecific binding of NatC to plastic
surfaces. A volume of 35 µL of the NatC/ribosome solution was underlaid with
80 µL of 80 S buffer supplemented with 30% (w/v) sucrose. Samples were cen-
trifuged for 70 min at 352,769 × g in a precooled (4 °C), TLA-100 rotor (Beckman).
The supernatant (i.e., 115 µL) was carefully removed and mixed with 30 µL of 5×
SDS sample buffer (250 mM TRIS-HCl, pH 6.8, 10% (w/v) SDS, 30% glycerol, 10%
(v/v) 2-mercaptoethanol, and 0.5% (w/v) bromophenol blue). The pellet was
resuspended in 145 µL resuspension buffer (35 µL 80 S buffer, 80 µL 80 S buffer
with 30% sucrose, and 30 µL 5× SDS sample buffer), and run on an SDS–PAGE gel
to analyze the amount of NatC and ribosome in the supernatant and pellet frac-
tions by western blot, using mouse α-FLAG M2 (Sigma-Aldrich, F3165, 1:10,000
dilution) and α-uL30 (α-RPL7, Abcam, ab72550, 1:3,000) as primary antibodies,
and horseradish peroxidase-coupled goat α-mouse IgG (Dianova, 115-035-003,
1:10,000) and α-goat IgG (Dianova, 111-035-003, 1:10,000) as secondary anti-
bodies. Chemoluminescence intensities of protein bands were analyzed with
ImageJ ImageJ 1.52a. Sedimentation assays were carried out in triplicate for NatC
WT and each mutant NatC construct.
Yeast genetics. S. cerevisiae WT (BY4741) and Naa35-deletion (Y00294) strains
were obtained from Euroscarf. The NAA35 gene (YEL053C), including 460 bp
upstream and 494 bps downstream of the NAA35 ORF, was amplified by PCR from
S. cerevisiae genomic DNA (strain BY4741), and cloned into the BamHI cloning
site of the pRS416 yeast centromere vector. Plasmids encoding Naa35-mutants
Tip1 (K500A, K501A, K503A, and K504A) and Tip2 (K511, R515, and R519) were
created using overlapping fragments, containing the desired mutations. Additional
27 bases (ATGGATTATAAAGATGATGATGATAAA) encoding for an additional
FLAG-tag were inserted in front of the start codon of NAA35-WT and mutant
genes for immunodetection of the NAA35 gene products. For vector transforma-
tions, S. cerevisiaeWT (BY4741) and NAA35-deletion (Y00294) strains were grown
overnight in 5 mL YPD (10 g L−1 yeast extract, 20 g L−1 peptone, and 2% (w/v)
glucose) medium at 30 °C. Cells were sedimented at 3000 × g, washed with 1 mL of
LiOAc mix (100 mM lithium acetate, 50 mM EDTA, 100 mM Tris-HCl, pH 7.6),
and resuspended in 100 µL LiOAc mix. To this, 10 µL of freshly boiled herring
sperm DNA (Sigma), 1 µg of plasmid DNA, and 700 µL of PEG mix (40% (w/v)
PEG 4000, 100 mM lithium acetate, 50 mM EDTA, 100 mM Tris-HCl, pH 7.6) was
added and the suspension was incubated for 30 min at 30 °C, followed by addition
of 48 µL DMSO and 15 min incubation at 42 °C. After addition of 3 mL YPD, cells
were grown for 1 h at 30 °C and plated on SD-ura (6.7 g L−1 yeast nitrogen base,
1.92 g L−1 SD medium supplement without uracil) agar plates containing 2% (w/v)
glucose, which were grown for 2–3 days at 30 °C. FLAG-tagged Naa35 could not be
detected by western blot, likely due to low Naa35 expression levels from the
endogenous promotor, as previously suggested58.
Yeast dilution spot assays. Single colonies of transformed S. cerevisiae WT and
NAA35-deletion strains were used for overnight cultivation at 30 °C in SD-ura
medium, containing 2% (w/v) glucose. After 16 h, cells were sedimented (5 min,
3000 × g) and resuspended in SD-ura medium, containing 3% (v/v) glycerol to an
OD600 of 1. Cells were grown at 30 °C for 3 h to deplete remaining glucose. For
dilution spot assays, yeast cells were initially diluted to an OD600 of 1. Subsequent
tenfold dilutions were made and a 48-pin multi-blot replicator was used to spot
cells onto SD-ura agar plates containing 2% (w/v) glucose or 3% (v/v) glycerol,
respectively. Plates were incubated at 37 °C for 3–5 days.
Statistics and reproducibility. Statistical parameters including the definitions and
exact value of n, deviations, p values, and the types of the statistical tests are
reported in the figures and corresponding figure legends or hereafter. The
SDS–PAGE analysis in Fig. 1d was repeated twice with identical results. The
underlying NatC complex purifications were performed three times for the NatC
complex containing full-length Naa35 (residues 1–733) and twice for the NatC
complex containing Naa35ΔN17 (residues 18–733). Replicate purifications showed
identical results. The NatC complex containing Naa35ΔN44 (residues 44–733) was
purified once. Statistical analyses were carried out using GraphPad Prism
version 6.01.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The atomic coordinates of NatC have been deposited in the Protein Data Bank with
accession numbers 6YGA (NatC, apo), 6YGB (NatC•CoA), 6YGC (NatC•CoA•MFHLV),
and 6YGD (NatC•CoA•MLRFV). The authors declare that the main data supporting the
findings of this study are available within the article and its Supplementary Information
files. All other supporting data, plasmids, and yeast strains developed in this study are
available from the corresponding author upon reasonable request. Source data are
provided with this paper.
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